Your fact-checks will appear here
Biotech company
As of 2025, the scientifically proven and FDA‑approved treatments for diabetes include multiple medication classes (insulins, GLP‑1 receptor agonists, GIP/GLP‑1 dual agonists, SGLT2 inhibitors, metfor...
Nine major drugmakers — Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech (Roche’s U.S. unit), Gilead Sciences, GSK (including ViiV), Merck, Novartis and Sanofi — agreed to sell selected me...
Yes — nine major pharmaceutical companies publicly agreed to lower the price of some of their medicines in deals announced by the Trump administration on Dec. 19, 2025, committing to “most-favored-nat...
Shareholders in targets of hostile takeovers commonly see a near-term jump in share price when an acquirer makes a public bid or a tender offer — often at a premium to the pre-bid market price — but l...